Interaction Between the Haptoglobin Genotype and Vitamin E on Cardiovascular Disease in Diabetes

被引：0
|
作者：
Irit Hochberg
Elliot M. Berinstein
Uzi Milman
Chen Shapira
Andrew P. Levy
机构：
[1] Rambam HealthCare Campus,Institute of Endocrinology, Diabetes and Metabolism
[2] Technion Israel Institute of Technology,Technion Faculty of Medicine
[3] Clalit Health Services,undefined
来源：
Current Diabetes Reports | 2017年 / 17卷
关键词：
Vitamin E; Haptoglobin; Cardiovascular disease; High-density lipoproteins; Oxidative stress;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Haptoglobin Genotype and Its Role in Diabetic Cardiovascular Disease
    Costacou, Tina
    Levy, Andrew P.
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2012, 5 (04) : 423 - 435
  • [12] Pharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability (vol 239, pg 232, 2015)
    Viener, Hilla-Lee
    Gorbatov, Rostic
    Vardi, Moshe
    Doros, Gheorghe
    Miller-Lotan, Rachel
    Zohar, Yaniv
    Sabo, Edmond
    Asleh, Rabea
    Levy, Nina S.
    Goldfarb, Levi J.
    Berk, Thomas A.
    Haas, Tali
    Shalom, Hadar
    Suss-Toby, Edith
    Kam, Adi
    Kaplan, Marielle
    Tamir, Ronit
    Ziskind, Anna
    Levy, Andrew P.
    ATHEROSCLEROSIS, 2015, 243 (02) : 356 - 356
  • [13] Haptoglobin genotype - A determinant of cardiovascular complication risk in type 1 diabetes
    Costacou, Tina
    Ferrell, Robert E.
    Orchard, Trevor J.
    DIABETES, 2008, 57 (06) : 1702 - 1706
  • [14] Pharmacogenomic application of the haptoglobin genotype in the prevention of diabetic cardiovascular disease
    Blum, Shany
    Milman, Uzi
    Shapira, Clien
    Levy, Andrew P.
    PHARMACOGENOMICS, 2008, 9 (08) : 989 - 991
  • [15] PHARMACOGENOMIC APPLICATION OF THE HAPTOGLOBIN GENOTYPE IN THE PREVENTION OF DIABETIC CARDIOVASCULAR DISEASE
    Levy, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [16] Changing the Face of Diabetic Care with Haptoglobin Genotype Selection and Vitamin E
    Levy, Nina S.
    Levy, Andrew P.
    RAMBAM MAIMONIDES MEDICAL JOURNAL, 2011, 2 (02):
  • [17] Haptoglobin Genotype Is a Determinant of Hemoglobin Adducts and Vitamin E Content in HDL
    Goldenstein, Hagit
    Levy, Nina S.
    Ward, John
    Costacou, Tina
    Levy, Andrew P.
    JOURNAL OF DIABETES RESEARCH, 2018, 2018
  • [18] Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype
    Farbstein, Dan
    Blum, Shany
    Pollak, Mordechai
    Asaf, Roy
    Viener, Hilla Lee
    Lache, Orit
    Asleh, Rabea
    Miller-Lotan, Rachel
    Barkay, Ido
    Star, Michael
    Schwartz, Avery
    Kalet-Littman, Shiri
    Ozeri, David
    Vaya, Jacob
    Tavori, Hagai
    Vardi, Moshe
    Laor, Arie
    Bucher, Stephen E.
    Anbinder, Yefim
    Moskovich, Doron
    Abbas, Nur
    Perry, Netta
    Levy, Yishai
    Levy, Andrew P.
    ATHEROSCLEROSIS, 2011, 219 (01) : 240 - 244
  • [19] Haptoglobin genotype and renal disease progression in type I diabetes
    Costacou, T.
    Ferrell, R. E.
    Orchard, T. J.
    DIABETOLOGIA, 2008, 51 : S473 - S474
  • [20] Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes
    Costacou, Tina
    Secrest, Aaron M.
    Ferrell, Robert E.
    Orchard, Trevor J.
    DIABETES & VASCULAR DISEASE RESEARCH, 2014, 11 (05): : 335 - 342
12345